The President said all generic drugs coming into the US will have a tariff rate of 100% after 2028, rising to 200% in 2029 in an effort to reshore drugmaking into America
The new AI-powered platform combines autonomous digital workers, interoperable healthcare data and compliance tools to help pharmaceutical manufacturers, medical device...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.